Delcath Systems, Inc.

DCTH US24661P8077

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Annual Insiders Turnover, USD ²

¹ annual and historical performance metrics are recalculated on a daily basis;
² represents the total value of insider transactions (both buying and selling);

Insider Activity

Person	Price	Shares	Total	Published	Completed
Aharon Gil	3.72 USD	26,882 Bought	100,001 USD	19/03/2024	19/03/2024
Salamon Steven A J	3.72 USD	26,882 Bought	100,001 USD	19/03/2024	19/03/2024
Vukovic Vojo CMO	3.00 USD	40,000 Bought	120,000 USD	12/12/2023	12/12/2023
Michel Gerard J CEO	2.94 USD	34,000 Bought	99,960 USD	08/12/2023	08/12/2023
Pennell Sandra VP	2.43 USD	30,000 Bought	72,900 USD	17/11/2023	17/11/2023
Hoffman David L. O	2.48 USD	40,000 Bought	99,200 USD	16/11/2023	16/11/2023
Vukovic Vojo CMO	2.48 USD	60,000 Bought	148,800 USD	16/11/2023	16/11/2023

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Delcath Systems, Inc. to your watchlist and receive automatic alerts for upcoming transactions.

Generate

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

• Insider Transaction Amount Distribution
• Insider Trading Seasonality
• Delta Correlation Analysis

 

Last	52W Low	52W High	All-Time Low	All-Time High	β

Company Insiders

Person / Entity	Transactions	Turnover, USD	Average, USD	First	Last
Vukovic Vojo	2	268,800.00	134,400.00	16/11/2023	12/12/2023
Salamon Steven A J	1	100,001.04	100,001.04	19/03/2024	19/03/2024
Aharon Gil	1	100,001.04	100,001.04	19/03/2024	19/03/2024
Michel Gerard J	1	99,960.00	99,960.00	08/12/2023	08/12/2023
Hoffman David L.	1	99,200.00	99,200.00	16/11/2023	16/11/2023
Pennell Sandra	1	72,900.00	72,900.00	17/11/2023	17/11/2023

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics

Delta Correlation	subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4	subscribe 🔒

⁴ represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

⁵ a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.